Posts

By John Kamp New legislation to spur medical innovation through new authorities for FDA and NIH is creating a lot of buzz in the Washington medical community, most of it very good. Indeed, even with outgoing FDA Commissioner Margaret Hamburg’s March 30 note of caution that regulatory innovation requires increased staff and other resources, the passage […]